Boxer Capital’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q1
Sell
-3,201,440
Closed -$188M 65
2023
Q4
$188M Hold
3,201,440
9.37% 1
2023
Q3
$139M Buy
3,201,440
+1,201,440
+60% +$52.3M 7.42% 1
2023
Q2
$72.3M Hold
2,000,000
3.35% 8
2023
Q1
$74.4M Hold
2,000,000
3.65% 9
2022
Q4
$90.6M Hold
2,000,000
4.78% 5
2022
Q3
$140M Hold
2,000,000
7.86% 1
2022
Q2
$134M Hold
2,000,000
8.5% 1
2022
Q1
$164M Hold
2,000,000
8.45% 1
2021
Q4
$293M Hold
2,000,000
11.39% 1
2021
Q3
$354M Hold
2,000,000
12.36% 1
2021
Q2
$323M Hold
2,000,000
11.4% 1
2021
Q1
$343M Buy
2,000,000
+234,440
+13% +$40.2M 11.62% 1
2020
Q4
$388M Hold
1,765,560
12.47% 1
2020
Q3
$293M Hold
1,765,560
10.13% 3
2020
Q2
$202M Hold
1,765,560
8.86% 2
2020
Q1
$136M Buy
1,765,560
+50,000
+3% +$3.84M 9.25% 1
2019
Q4
$221M Hold
1,715,560
12.5% 1
2019
Q3
$134M Hold
1,715,560
9.69% 2
2019
Q2
$177M Hold
1,715,560
15.19% 1
2019
Q1
$126M Buy
1,715,560
+150,000
+10% +$11M 14.54% 1
2018
Q4
$66.4M Hold
1,565,560
8.21% 5
2018
Q3
$73.7M Hold
1,565,560
8.18% 5
2018
Q2
$77.2M Buy
1,565,560
+193,050
+14% +$9.52M 8.74% 3
2018
Q1
$42.1M Hold
1,372,510
4.5% 9
2017
Q4
$25M Buy
1,372,510
+334,516
+32% +$6.1M 4.58% 7
2017
Q3
$12.1M Hold
1,037,994
2.76% 11
2017
Q2
$3.79M Hold
1,037,994
0.9% 17
2017
Q1
$5.4M Buy
1,037,994
+280,059
+37% +$1.46M 1.18% 13
2016
Q4
$3.6M Hold
757,935
1.39% 12
2016
Q3
$5.01M Hold
757,935
2.25% 12
2016
Q2
$4.14M Hold
757,935
3.67% 13
2016
Q1
$16.2M Sell
757,935
-1,265,297
-63% -$27.1M 15.87% 1
2015
Q4
$63.9M Buy
+2,023,232
New +$63.9M 55.2% 1